Tightened Clinical Trial Regulations in India Result in Fewer Pharmaceutical Trials
Drug companies have often conducted clinical trials in India because of the country’s low costs, patient availability and technically proficient personnel. But in late 2012, amended regulations made securing permission for a clinical trial a much more rigorous process. This has lowered... Read More